Cynthia Jean Miley

Title: Cynthia Jean Miley: Innovator in Pharmaceutical Chemistry

Introduction

Cynthia Jean Miley is a notable inventor based in Cincinnati, OH (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on prostaglandin analogs. Her research has the potential to impact the treatment of various diseases and conditions.

Latest Patents

Cynthia holds a patent for "Aromatic C.sub.16 -C.sub.20 -substituted tetrahydro prostaglandins." This invention provides novel PGF analogs, which are compounds that can be utilized in the treatment of bone disorders and glaucoma. The patent details a specific structure for these compounds, including their optical isomers, diastereomers, and enantiomers, along with pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides. The compounds are designed to be effective in pharmaceutical compositions aimed at treating these medical conditions.

Career Highlights

Cynthia is associated with The Procter & Gamble Company, where she applies her expertise in pharmaceutical development. Her work has led to advancements in the understanding and application of prostaglandin analogs in medicine.

Collaborations

Cynthia has collaborated with notable colleagues such as John August Wos and Mitchell Anthony DeLong. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Cynthia Jean Miley's contributions to pharmaceutical chemistry exemplify the impact of innovation in medical treatments. Her work continues to pave the way for advancements in the treatment of bone disorders and glaucoma.